(INDOL-3-YL)-CYCLOALKYL]-3-SUBSTITUTED AZETIDINES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS - Patent 1228065

(19)

(11)

EP 1 228 065 A1

(12)

(43)	Date of publication:
	07.08.2002 Bulletin 2002/32

(21)	Application number: 00976731.0

(22)	Date of filing: 31.10.2000

(51)	International Patent Classification (IPC)⁷: C07D 403/08, A61K 31/404, A61P 25/24

(86)	International application number:
	PCT/US0029/954

(87)	International publication number:
	WO 0134/598 (17.05.2001 Gazette 2001/20)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

08.11.1999 US 436119

(71)	Applicant: Wyeth
	Madison, New Jersey 07940-0874 (US)

(72)	Inventors:
	Asselin, Magda Mahwah, NJ 07430 (US) Ellingboe, John, Watson Ridgewood, NJ 07450 (US) Mewshaw, Richard Eric King of Prussia, PA 19406 (US)

(74)	Representative: Wileman, David Francis Dr.
	Wyeth Pharmaceuticals,Huntercombe Lane South,Taplow Maidenhead,Berkshire SL6 OPH Maidenhead,Berkshire SL6 OPH (GB)

(54)	(INDOL-3-YL)-CYCLOALKYL]-3-SUBSTITUTED AZETIDINES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS